Skip to main content

Advertisement

Log in

Recruitment of Plasma Membrane GABA-A Receptors by Submembranous Gephyrin/Collybistin Clusters

  • Original Research
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

A Correction to this article was published on 24 February 2021

This article has been updated

Abstract

It has been shown that subunit composition is the main determinant of the synaptic or extrasynaptic localization of GABAA receptors (GABAARs). Synaptic and extrasynaptic GABAARs are involved in phasic and tonic inhibition, respectively. It has been proposed that synaptic GABAARs bind to the postsynaptic gephyrin/collybistin (Geph/CB) lattice, but not the typically extrasynaptic GABAARs. Nevertheless, there are no studies of the direct binding of various types of GABAARs with the submembranous Geph/CB lattice in the absence of other synaptic proteins, some of which are known to interact with GABAARs. We have reconstituted GABAARs of various subunit compositions, together with the Geph/CB scaffold, in HEK293 cells, and have investigated the recruitment of surface GABAARs by submembranous Geph/CB clusters. Results show that the typically synaptic α1β3γ2 GABAARs were trapped by submembranous Geph/CB clusters. The α5β3γ2 GABAARs, which are both synaptic and extrasynaptic, were also trapped by Geph/CB clusters. Extrasynaptic α4β3δ GABAARs consistently showed little or no trapping by the Geph/CB clusters. However, the extrasynaptic α6β3δ, α1β3, α6β3 (and less α4β3) GABAARs were highly trapped by the Geph/CB clusters. AMPA and NMDA glutamate receptors were not trapped. The results suggest: (I) in the absence of other synaptic molecules, the Geph/CB lattice has the capacity to trap not only synaptic but also several typically extrasynaptic GABAARs; (II) the Geph/CB lattice is important but does not play a decisive role in the synaptic localization of GABAARs; and (III) in neurons there must be mechanisms preventing the trapping of several typically extrasynaptic GABAARs by the postsynaptic Geph/CB lattice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of Data and Materials

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Change history

References

Download references

Acknowledgements

We thank Profs. K. Harvey (UCL School of Pharmacy, London, UK) and R.J. Harvey (University of the Sunshine Coast, Sippy Downs, Australia) for providing the CB plasmids and Profs. J.M. Fritschy and S.K. Tyagarajan (Institute of Pharmacology and Toxicology, University of Zurich, Switzerland) for the EGFP-Geph plasmid. We also thank the late Dr Peter Seeburg (Max Planck-Institute for Medical Research, Heidelberg) for GluA1, GluA2, GluN1, GluN2B and mycGluN2B plasmids. We also thank Ms. Toni Vella for her participation in some experiments.

Funding

This research was supported by the NIH-NINDS Grant R01NS038752 to A.L.D. and a University of Connecticut Research Incentive Program grant to A.L.D.

Author information

Authors and Affiliations

Authors

Contributions

ALD involved in the study concept and design. SG, T-TC and KK participated in acquisition of data. SG, T-TC, KK and ALD involved in analysis and interpretation of data. ALD drafted the manuscript. SG and ALD involved in critical revision of the manuscript for important intellectual content. SG participated in statistical analysis. SG and ALD supervised the study. ALD obtained the funding.

Corresponding author

Correspondence to Angel L. De Blas.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: the figures in supplementary material were swapped and now it has been corrected.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (TIF 3686 KB)

Fig. S1. (A): HEK293 cells were co-transfected with EGFP-Geph and HA-CB2SH3-; Fixed and permeabilized; Ms anti-HA (red). (B-C) HEK293 cells were co-transfected with EGFP-Geph and myc-CB2SH3- and either fixed and non-permeabilized (no Triton X-100; B), or fixed and permeabilized (C); Ms anti-Geph (red), Rb anti-CB (blue). Scale bar = 10 μm for A and 12 μm for B&C.

Supplementary file2 (TIF 5045 KB)

Fig. S2. (A-B): Triple-label immunofluorescence of cells co-transfected with α1, β3, γ2 and either EGFP-Geph (A) or myc-CB2SH3- (B). Live-cell two-step capping in A with no permeabilization. Live cell two-step capping with anti-GABAAR subunit antibodies followed by fixation and permeabilization for anti-myc labeling. Rb anti- γ2 (red), and either EGFP-Geph fluorescence (A; green) or Ms anti-myc (B; blue). (C) Triple-label immunofluorescence of cells co-transfected with α1, β3, and γ2. Fixed and permeabilized; GP anti-α1 (green); Ms anti-β2/3(blue); Rb anti-γ2 (red). (D-E): HEK293 cells co-transfected with α1, β3, γ2, EGFP-Geph and myc-CB2SH3-. Fixed and permeabilized; EGFP fluorescence (green); Ms anti-myc (blue in D); Ms anti-β2/3 (blue in E); Rb anti-γ2 (red). Scale bar = 11.2 μm for A,B & E; 25 μm for C; 13.4 μm for D.

Supplementary file3 (TIF 5618 KB)

Fig. S3. (A): Triple-label fluorescence of fixed and permeabilized cells that were co-transfected with α1, β3, EGFP-Geph and myc-CB2SH3-. Rb anti-α1 (red); EGFP fluorescence (green); Ms anti-myc (blue). (B): Triple-label fluorescence of cells that were co-transfected with α1, β3, EGFP-Geph and myc-CB2SH3-. Surface labeling was done by live-cell incubation with Abs. Ms anti-β2/3 (red); Rb anti-α1 (blue); EGFP-Geph fluorescence (green). (C) Triple-label fluorescence of fixed and permeabilized cells that were co-transfected with β3, EGFP-Geph and myc-CB2SH3-. Ms anti-β2/3; EGFP fluorescence (green); Rb anti-myc (blue). (D) Triple-label fluorescence of cells that were co-transfected with β3, EGFP-Geph and myc-CB2SH3-. Surface labeling was done by live-cell incubation with Abs. Ms anti-β2/3 (blue); EGFP fluorescence (green); Rb anti-CB (red). (E): Double-label fluorescence of fixed and permeabilized cells that were co-transfected with γ2, EGFP-Geph and myc-CB2SH3-. EGFP-Geph fluorescence (green); Rb anti-γ2 (red). (F): Double-label fluorescence of fixed and permeabilized cells co-transfected with α1, EGFP-Geph and myc-CB2SH3-. Rb anti-α1 (red); EGFP-Geph fluorescence (green). Scale bar = 23.4 µm for A; 14.4 µm for B; 18 µm for C&D to P; 10 µm for E&F

Supplementary file4 (TIF 5839 KB)

Fig. S4. (A-B): Cells transfected with α4 (A) or mycδ (B) react with Rb anti-α4 or Ms anti-myc, respectively, in fixed and permeabilized cells. (C): Cells were co-transfected with α4, β3-EGFP and mycδ. Live cell incubation with Rb anti-α4 (blue), Ms anti-myc (red) and β3-EGFP fluorescence (green) shows capping and co-localization of the three of GABAAR subunits at the cell surface. Second and fourth panels show overlays of blue and red, and green and red, respectively. (D&E): Cells were co-transfected with α4, β3, and mycδ, EGFP-Geph and HA-CB2SH3-. Cells were fixed and permeabilized before incubation with Ms anti-myc (red) and Rb α4 (blue). Most cells show little to no co-localization (D) while few show some co-localization (E). (F): Cells were co-transfected with α4 and β3. Fixed and non-permeabilized transfected cells were incubated with Rb anti-α4 (red); Ms anti-β2/3 (blue). (G&H): HEK293 cells were co-transfected with α5, β3-EGFP, mycγ2. (G): Cells were fixed and permeabilized before incubation with antibodies. (H): Live cell incubation of transfected cells with Rb anti-α5 (red) and Ms anti-myc (blue) shows capping of the GABAARs including β3-EGFP (green) at the cell surface. Scale bar = 10 µm for A&B; 14 µm for C; 11.3 µm for D; 5.6 µm for E; 7.5 µm for F; 17.2 µm for G; and 6.8 µm for H

Supplementary file5 (TIF 2370 KB)

Fig. S5. Surface AMPA and NMDA glutamate receptors do not associate with submembranous Geph/CB2SH3- clusters. Triple-label fluorescence. (A-C): Cells were co-transfected with GluA1, GluA2, EGFP-Geph and HA-CB2SH3-. In A cells were fixed and permeabilized before labeling. Ms anti-GluA2 (red) and Rb anti-GluA1 (blue); In B-C, immunolabelling was done after fixation without permeabilization. (B) surface labeling of GluA2 (red) and GluA1 (blue). There is no surface labeling of GluA1 because Rb anti-GluA1 recognizes an intracellular epitope. (C) Confocal image overlay of GluA2 (blue) and EGFP-Geph (green). (D-F): Cells were co-transfected with GluN1, mycGluN2B, EGFP-Geph and HA-CB2SH3-. In D, cells were fixed and permeabilized before labeling. In E-F immunolabelling was done after fixation without permeabilization. Rb anti-myc (red) and EGFP-Geph fluorescence (green); J shows a confocal image. Scale bar = 6.6 µm for A; 10 µm for B&D and 8.3 µm for C,E-F

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

George, S., Chiou, TT., Kanamalla, K. et al. Recruitment of Plasma Membrane GABA-A Receptors by Submembranous Gephyrin/Collybistin Clusters. Cell Mol Neurobiol 42, 1585–1604 (2022). https://doi.org/10.1007/s10571-021-01050-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-021-01050-1

Keywords

Navigation